Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

5-Fluorouracil Versus Capecitabine as Perioperative Treatment for Locally Advanced Rectal Cancer. a Randomized Phase III Trial

NCT01500993 is registered in ClinicalTrials.gov with Universitätsmedizin Mannheim as lead sponsor.

NCT NCT01500993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
5-Fluorouracil Versus Capecitabine as Perioperative Treatment for Locally Advanced Rectal Cancer. a Randomized Phase III Trial
Lead sponsor
Universitätsmedizin Mannheim
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
March 31, 2011
Enrollment
401 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer